• "Spreading the ideas of freedom loving people on matters regarding high finance, politics, constructionist Constitution, and mental masturbation of all types"

Chiron and GSK- GlaxoSmithKline Corona Virus Patents? | patent US2006257852 | European patent EP3172319B1 for Vaccine ?

MIavatar

Silver Miner
Joined
Nov 15, 2016
Messages
521
Likes
293
#1
Not sure if you guys have seen this. What do you think? Then there was a vaccine patent in the EU?

In 2006, USA company “Chiron” Corp applied for & was granted the Corona virus patent?


patent US2006257852
https://pubchem.ncbi.nlm.nih.gov/patent/US2006257852#section=Patent-Abstract
patent View

Severe acute respiratory syndrome coronavirus


Patent:


US2006257852
This web page summarizes information in PubChem about patent US2006257852. This includes chemicals mentioned, as reported by PubChem contributors, as well as other content, such as title, abstract, and International Patent Classification (IPC) codes. To read more about how this page was constructed, please visit the PubChem patents help page.
1Primary Patent Identifier

New Window


US2006257852

2Patent Submission Date

New Window


2006/11/16

3Patent Title

New Window


Severe acute respiratory syndrome coronavirus

4Patent Abstract

New Window


An outbreak of a virulent respiratory virus, now known as Severe Acute Respiratory Syndrome (SARS), was identified in Hong Kong, China and a growing number of countries around the world in 2003. The invention relates to nucleic acids and proteins from the SARS coronavirus. These nucleic acids and proteins can be used in the preparation and manufacture of vaccine formulations, diagnostic reagents, kits, etc. The invention also provides methods for treating SARS by administering small molecule antiviral compounds, as well as methods of identifying potent small molecules for the treatment of SARS.

5Patent URL

New Window
http://appft.uspto.gov/netacgi/nph-Parser?p=1&u=/netahtml/PTO/search-adv.html&r=1&f=G&l=50&d=PG01&s1=20060257852.PN.&OS=PN/20060257852&RS=PN/20060257852

6Patent Identifier Synonyms

New Window


US20060257852


US20060257852.A1.20061116


US20060257852A1


US2006257852.A1.20061116


US2006257852A1

7Patent Applicant

New Window


CHIRON CORP [US]

8Patent Inventor

New Window


CHIEN DAVID [US]


DONNELLY JOHN [US]


GREGERSEN JENS P [DE]


HAN JANG [US]


HOUGHTON MICHAEL [US]


KLENK HANS D [DE]


MASIGNANI VEGA [IT]


POLO JOHN M [US]


RAPPUOLI RINO [IT]


SEO MI-YOUNG [KR]


SONG HYUN C [US]


STADLER KONRAD [AU]


VALIANTE NICHOLAS [US]


WEINER AMY [US]

9Patent Chemicals

New Window

9.1PubChem Compounds
New Window
1,804 items
View More Rows & Details
That was sold to pharmaceutical & vaccine making giant “GSK- GlaxoSmithKline..
Now we have talks about no vaccine and how we are at least a year out from this. that’s a lie
In 2014 a Vaccine was patented. European patent EP3172319B1 .

DETAILED DESCRIPTION


55
[0038] The present invention provides a coronavirus comprising a variant replicase gene which, when expressed in
the coronavirus, causes the virus to have reduced pathogenicity compared to a corresponding coronavirus which com-
prises the wild-type replicase gene.

EP 3 172 319 B1


CORONAVIRUS

[0039] Gammacoronavirus is a genus of animal virus belonging to the family Coronaviridae. Coronaviruses are en-
veloped viruses with a positive-sense single-stranded RNA genome and a helical symmetry.
[0040] The genomic size of coronaviruses ranges from approximately 27 to 32 kilobases, which is the longest size for
any known RNA virus.

[0041] Coronaviruses primarily infect the upper respiratory or gastrointestinal tract of mammals and birds. Five to six
different currently known strains of coronaviruses infect humans. The most publicized human coronavirus, SARS-CoV
which causes severe acute respiratory syndrome (SARS), has a unique pathogenesis because it causes both upper
and lower respiratory tract infections and can also cause gastroenteritis. Middle East respiratory syndrome coronavirus
(MERS-CoV) also causes a lower respiratory tract infection in humans. Coronaviruses are believed to cause a significant
percentage of all common colds in human adults.

[0042] Coronaviruses also cause a range of diseases in livestock animals and domesticated pets, some of which can
be serious and are a threat to the farming industry. Economically significant coronaviruses of livestock animals include
infectious bronchitis virus (IBV) which mainly causes respiratory disease in chickens and seriously affects the poultry
industry worldwide; porcine coronavirus (transmissible gastroenteritis, TGE) and bovine coronavirus, which both result
in diarrhoea in young animals. Feline coronavirus has two forms, feline enteric coronavirus is a pathogen of minor clinical
significance, but spontaneous mutation of this virus can result in feline infectious peritonitis (FIP), a disease associated
with high mortality.
https://randythym.com/2020/01/25/th...rus-has-an-english-patent-number-ep3172319b1/

The corona virus that suddenly appeared in China in the Wuhan region and that is said to have started on an animal market is covered by an English patent. This is a patent number EP3172319B1 developed by Erica Bickerton on it Pirbright Institute in Surrey, England. The Pirbright Institute (Bill & Melinda Gates) specializes in the study of infectious diseases in farm animals.
It was granted approval in 2019.
 

the_shootist

Trump 2020
Midas Member
Midas Supporter ++
Joined
May 31, 2015
Messages
42,082
Likes
67,105
#2
Big pharma always has their hands in there somewhere
 

Buck

Village Idiot
Midas Member
Site Supporter ++
Joined
Apr 13, 2011
Messages
10,088
Likes
10,027
#3
so, they patent the virus on one side of the planet, then, patent the cure on the other side

how in the hell is the average citizen, of any country on the planet, supposed to keep up with that charade?



oh, wait, we're not supposed to have to do that
 

MIavatar

Silver Miner
Joined
Nov 15, 2016
Messages
521
Likes
293
#4
thought Id put some info about Chiron corp here.


https://en.wikipedia.org/wiki/Chiron_Corporation
Chiron Corporation (/ˈkaɪrɒn/ KY-ron)[1] was an American multinational biotechnology firm based in Emeryville, California that was acquired by Novartis on April 20, 2006. It had offices and facilities in eighteen countries on five continents. Chiron's business and research was in three main areas: biopharmaceuticals, vaccines, and blood testing. Chiron's vaccines and blood testing units were combined to form Novartis Vaccines and Diagnostics, while Chiron BioPharmaceuticals was integrated into Novartis Pharmaceuticals. In 2014, Novartis completed the sale of its blood transfusion diagnostics unit to Grifols and announced agreements for the sale of its vaccines unit to GlaxoSmithKline.[2]


Early history
Chiron was founded in 1981 by chairman, William J. Rutter, president and chief executive, Professor Edward Penhoet, and vice president for research, Pablo DT Valenzuela. All were academics from the University of California; Penhoet at Berkeley, where he continued to lecture, and the others from San Francisco.[1] Chiron formed a partnership with the Swiss pharmaceutical giant, Ciba-Geigy Ltd.,[1] through the Biocine Company,[3][4] to use genetic engineering to develop vaccines and to treat, prevent and diagnose diseases such as AIDS, herpes and malaria.[1][5] Other partnerships included Thicon Inc. to develop a growth factor hormone for the treatment of wounds and Merck & Co to develop an improvement to their existing hepatitis B vaccine.[1] In 1986, Professor Penhoet said: "Our business strategy is to dominate small markets rather than take a small presence in a broad market." The niche that Chiron was focusing on was ophthalmology, which Mr. Penhoet said was "big enough to be interesting, but small enough to service with 40 salespeople."[1] Professor Penhoet also stated that Chiron was set up to provide the enabling technology for others to use under license,[1] and later saying that Chiron was "as close to a virtual corporation as you can be", with few fixed assets but more relationships.[6]
 

TAEZZAR

LADY JUSTICE ISNT BLIND, SHES JUST AFRAID TO WATCH
Midas Member
Midas Supporter ++
GIM Hall Of Fame
Joined
Apr 2, 2010
Messages
18,166
Likes
34,432
Location
ORYGUN
#5
My understanding is that each year the virus is a bit different & they have to wait for the "strain" to develop before they can come up with a vaccine for that strain.
NOW this does not, in any way, discount ANY backhanded, dirty tricks, that big pharma is capable of ! :angry then happy::make happy:
 

bemac

Midas Member
Midas Member
Joined
Nov 5, 2010
Messages
5,594
Likes
4,757
#6
Fake news.

Coronavirus is a type of virus. It's not a single virus that's new. What is new is a type of Coronavirus that can cause COVID 19.